At the Eleventh Hour, Harpoon Therapeutics Signs up to Join the 2018 IPO Game

South San Francisco-based Harpoon Therapeutics is looking to tap into the white-hot IPO magic that has been one of the hallmarks of 2018 for the biotech industry. The company filed its registration statement with the U.S. Securities and Exchange Commission on Thursday.